Amylyx Pharmaceuticals (AMLX) Shares Issued (2021 - 2026)

Amylyx Pharmaceuticals' Shares Issued history runs 6 years deep, the most recent figure standing at $7.2 million for Q1 2026.

• In Q1 2026, Shares Issued rose 638.04% year-over-year to $7.2 million; the TTM figure through Mar 2026 stood at $10.3 million (up 519.93% YoY), while the FY2025 annual figure was $4.1 million, up 91.23% from the prior year.
• Shares Issued was $7.2 million for Q1 2026 at Amylyx Pharmaceuticals, up from $376000.0 in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $200.9 million in Q1 2022 to a low of -$200.6 million in Q3 2022.
• Historically, Shares Issued has averaged $1.4 million across 5 years, with a median of $977000.0 in 2023.
• Biggest YoY gain for Shares Issued was 647954.84% in 2022; the steepest drop was 122446.95% in 2022.
• A 5-year view of Shares Issued shows it stood at $1.9 million in 2022, then sank by 82.12% to $347000.0 in 2023, then sank by 57.35% to $148000.0 in 2024, then soared by 154.05% to $376000.0 in 2025, then jumped by 1803.99% to $7.2 million in 2026.
• The last three Shares Issued figures came in at $7.2 million (Q1 2026), $376000.0 (Q4 2025), and $2.7 million (Q3 2025), per Business Quant data.